Bipolar spectrum in prostate cancer patients and its role in stress related symptoms.
affective disorders
bipolar disorder
cancer
comorbidity
mood disorders
oncology
prostate cancer
Journal
Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
11
12
2022
received:
01
11
2022
accepted:
05
01
2023
pubmed:
12
1
2023
medline:
15
3
2023
entrez:
11
1
2023
Statut:
ppublish
Résumé
Studies show significant co-occurrence of bipolar disorder and prostate cancer, as well as the presence of shared genes associated with both diseases. Our aim was to evaluate whether prostate cancer patients present bipolar spectrum symptoms and to establish their possible associations with stress related symptoms during diagnosis and the course of the cancer therapy. 200 participants were enrolled to this study: 100 prostate cancer patients and 100 healthy males. Bipolar spectrum symptoms were measured with the use of Mood Disorder Questionnaire and Hypomania Checklist-32 (HCL-32). Stress related symptoms were rated with The Impact of Events Scale-Revised (IES-R), Perceived Stress Scale-10 (PSS-10) and Generalised Self-Efficacy Scale (GSES). In comparison to healthy controls group, prostate cancer patients have shown higher HCL-32 scores. Mood Disorder Questionnaire measures were associated with more severe stress related to prostate cancer diagnosis and treatment reflected by higher scores of IES-R and its subscales (Avoidance, Intrusions and Hyperarousal). Mood Disorder Questionnaire, HCL-32, PSS-10, IES-R and GSES measures were not associated with clinical characteristics of prostate cancer severity. Cross-sectional study model precluded identification of causal relationship among variables. Bipolar spectrum symptoms and stress related measures were based on auto-questionnaires. To our best knowledge, this is the first study evaluating bipolar spectrum symptoms in prostate cancer patients. We have shown that this clinical group presents increased bipolarity traits compared to healthy individuals. Moreover, bipolar spectrum symptoms were associated with more severe stress related to the prostate cancer diagnosis and its treatment, reflected in avoidance, hyperarousal, and intrusions.
Sections du résumé
BACKGROUND
Studies show significant co-occurrence of bipolar disorder and prostate cancer, as well as the presence of shared genes associated with both diseases. Our aim was to evaluate whether prostate cancer patients present bipolar spectrum symptoms and to establish their possible associations with stress related symptoms during diagnosis and the course of the cancer therapy.
METHODS
200 participants were enrolled to this study: 100 prostate cancer patients and 100 healthy males. Bipolar spectrum symptoms were measured with the use of Mood Disorder Questionnaire and Hypomania Checklist-32 (HCL-32). Stress related symptoms were rated with The Impact of Events Scale-Revised (IES-R), Perceived Stress Scale-10 (PSS-10) and Generalised Self-Efficacy Scale (GSES).
RESULTS
In comparison to healthy controls group, prostate cancer patients have shown higher HCL-32 scores. Mood Disorder Questionnaire measures were associated with more severe stress related to prostate cancer diagnosis and treatment reflected by higher scores of IES-R and its subscales (Avoidance, Intrusions and Hyperarousal). Mood Disorder Questionnaire, HCL-32, PSS-10, IES-R and GSES measures were not associated with clinical characteristics of prostate cancer severity.
LIMITATIONS
Cross-sectional study model precluded identification of causal relationship among variables. Bipolar spectrum symptoms and stress related measures were based on auto-questionnaires.
CONCLUSIONS
To our best knowledge, this is the first study evaluating bipolar spectrum symptoms in prostate cancer patients. We have shown that this clinical group presents increased bipolarity traits compared to healthy individuals. Moreover, bipolar spectrum symptoms were associated with more severe stress related to the prostate cancer diagnosis and its treatment, reflected in avoidance, hyperarousal, and intrusions.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
438-445Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
Kraepelin E. Lectures on Clinical Psychiatry. 3rd ed. William Wood; 1917. 3rd edn. Wood W, editor. New York, NY; 1917.
Phelps J, Angst J, Katzow J, Sadler J. Validity and utility of bipolar spectrum models. Bipolar Disord. 2008;10(1 PART 2):179-193. https://doi.org/10.1111/j.1399-5618.2007.00562.x
Siwek M, Dudek D, Drozdowicz K, et al. Temperamental dimensions of the TEMPS-A in male and female subjects engaging in extreme or/and high risk sports. J Affect Disord. 2015;170:66-70. https://doi.org/10.1016/j.jad.2014.08.036
Chrobak AA, Tereszko A, Dembinska-Krajewska D, et al. The role of affective temperaments assessed by the Temperament Evaluation of Memphis, Pisa and San Diego-Autoquestionnaire (TEMPS-A) in the relationship between morningness-eveningness and bipolarity. J Affect Disord. 2018;232:83-88. https://doi.org/10.1016/j.jad.2018.02.017
Akiskal HS. The emergence of the bipolar spectrum: validation along clinical-epidemiologic and familial-genetic lines. Psychopharmacol Bull. 2007;40:99-115.
Goodwin R, Jamison K. Manic-Depressive Illness. 2nd ed. Oxford University Press; 2007.
DisGeNET - a Database of Gene-Disease Associations [Internet]. [cited 2022 Aug 2]. https://www.disgenet.org/browser/0/1/2/C0005586/0/25/16681/_a/_b./-ngenes/
Kesebir S. Metabolic syndrome and childhood trauma: also comorbidity and complication in mood disorder. World J Clin Cases. 2014;2(8):332. https://doi.org/10.12998/wjcc.v2.i8.332
Kesebir S, Koc MI, Yosmaoglu A. Bipolar spectrum disorder may be associated with family history of diseases. J Clin Med Res. 2020;12(4):251-254. https://doi.org/10.14740/jocmr4143
European Association of Urology (EAU). Oncology Guidelines; Prostate Cancer; 2022. https://uroweb.org/guidelines/prostate-cancer
Chen PM, Chen SC, Liu CJ, et al. The association between prostate cancer and mood disorders: a nationwide population-based study in Taiwan. Int Psychogeriatr. 2015;27(3):481-490. https://doi.org/10.1017/s104161021400218x
Belkhiri A, Zhu S, El-Rifai W. DARPP-32: from neurotransmission to cancer. Oncotarget. 2016;7(14):17631-17640. https://doi.org/10.18632/oncotarget.7268
Fervaha G, Izard JP, Tripp DA, Rajan S, Leong DP, Siemens DR. Depression and prostate cancer: a focused review for the clinician. Urologic Oncol. 2019;37(4):282-288. Elsevier Inc. https://doi.org/10.1016/j.urolonc.2018.12.020
Weber BA, Roberts BL, Mills TL, Chumbler NR, Algood CB. Physical and emotional predictors of depression after radical prostatectomy. Am J Men's Health. 2008;2(2):165-171. https://doi.org/10.1177/1557988307312222
Fang F, Keating NL, Mucci LA, et al. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst. 2010;102(5):307-314. https://doi.org/10.1093/jnci/djp537
Khan NF, Ward AM, Watson E, Rose PW. Consulting and prescribing behaviour for anxiety and depression in long-term survivors of cancer in the UK [Internet]. Eur J Cancer. 2010;46(18):3339-3344. https://doi.org/10.1016/j.ejca.2010.07.035
Bill-Axelson A, Garmo H, Nyberg U, et al. Psychiatric treatment in men with prostate cancer--results from a Nation-wide, population-based cohort study from PCBaSe Sweden. Eur J Cancer. 2011;47(14):2195-2201. https://doi.org/10.1016/j.ejca.2011.04.022
Kapczinski F, Vieta E, Andreazza AC, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32(4):675-692. https://doi.org/10.1016/j.neubiorev.2007.10.005
Cavazzoni P, Grof P, Duffy A, et al. Heterogeneity of the risk of suicidal behavior in bipolar-spectrum disorders [Internet]. Bipolar Disord. 2007;9(4):377-385. https://doi.org/10.1111/j.1399-5618.2007.00516.x
Rybakowski JK. Bipolarity and inadequate response to antidepressant drugs: clinical and psychopharmacological perspective. J Affect Disord. 2012;136(1-2):e13-e19. https://doi.org/10.1016/j.jad.2011.05.005
Nitzburg GC, Russo M, Cuesta-Diaz A, et al. Coping strategies and real-world functioning in bipolar disorder [Internet]. J Affect Disord. 2016;198:185-188. https://doi.org/10.1016/j.jad.2016.03.028
Siwek M, Dudek D, Rybakowski J, Łojko D, Pawłowski T, Kiejna A. Mood disorder questionnaire-characteristic and indications. Psychiatr Pol. 2009;43(3):287-299.
Rybakowski JK, Angst J, Dudek D, et al. Polish version of the Hypomania Checklist (HCL-32) scale: the results in treatment-resistant depression. Eur Arch Psychiatr Clin Neurosci. 2010;260(2):139-144. https://doi.org/10.1007/s00406-009-0030-4
Chrobak AA, Siwek M, Dudek D, Rybakowski JK. Content overlap analysis of 64 (hypo)mania symptoms among seven common rating scales. Int J Methods Psychiatr Res. 2018;27(3):e1737. https://doi.org/10.1002/mpr.1737
Wang YY, Xu DD, Liu R, et al. Comparison of the screening ability between the 32-item Hypomania Checklist (HCL-32) and the Mood Disorder Questionnaire (MDQ) for bipolar disorder: a meta-analysis and systematic review. Psychiatr Res. 2019;273:461-466. https://doi.org/10.1016/j.psychres.2019.01.061
Juczyński Z, Ogińska-Bulik N. Measurement of post-traumatic stress disorder - polish version of impact event scale-revised. Psychiatria. 2009;6(1):15-25.
Juczyński Z, Ogińska-Bulik N. Narzędzia Pomiaru Stresu I Radzenia Sobie Ze Stresem. Pracownia Testów Psychologicznych Polskiego Towarzystwa Psychologicznego; 2009.
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385-396. https://doi.org/10.2307/2136404
Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In: Measures in health psychology: A user’s portfolio; 1995.
Jurczyński Z. Poczucie własnej skuteczności - teoria i pomiar. Folia Psychol 2004;4:11-23.
Fervaha G, Izard JP, Tripp DA, Rajan S, Leong DP, Siemens DR. Depression and prostate cancer: a focused review for the clinician. Urol Oncol. 2019;37(4):282-288. https://doi.org/10.1016/j.urolonc.2018.12.020
Sharpley CF, Bitsika V, Christie DR. The role of Melancholia in prostate cancer patients’ depression [Internet]. BMC Psychiatr. 2011;11(1):201. https://doi.org/10.1186/1471-244x-11-201
Parker G, Roy K, Wilhelm K, Mitchell P, Hadzi-Pavlovic D. The nature of bipolar depression: implications for the definition of melancholia. J Affect Disord. 2000;59(3):217-224. https://doi.org/10.1016/s0165-0327(99)00144-5
Hartung TJ, Moustsen IR, Larsen SB, et al. Antidepressant prescriptions and associated factors in men with prostate cancer and their female partners. J Cancer Surviv. 2021;15(4):536-545. https://doi.org/10.1007/s11764-020-00947-y
Kiejna A, Pawłowski T, Dudek D, et al. The utility of Mood Disorder Questionnaire for the detection of bipolar diathesis in treatment-resistant depression. J Affect Disord. 2010;124(3):270-274. https://doi.org/10.1016/j.jad.2009.12.003
Smith DP, Calopedos R, Bang A, et al. Increased risk of suicide in New South Wales men with prostate cancer: analysis of linked population-wide data. PLoS One. 2018;13(6):e0198679. https://doi.org/10.1371/journal.pone.0198679
Recklitis CJ, Zhou ES, Zwemer EK, Hu JC, Kantoff PW. Suicidal ideation in prostate cancer survivors: understanding the role of physical and psychological health outcomes. Cancer. 2014;120(21):3393-3400. https://doi.org/10.1002/cncr.28880
Curtis R, Groarke A, Sullivan FJ. Stress and self-efficacy predict psychological adjustment at diagnosis of prostate cancer. Sci Rep. 2014;4(1):5569. https://doi.org/10.1038/srep05569
Roesch SC, Adams L, Hines A, et al. Coping with prostate cancer: a meta-analytic review [Internet]. J Behav Med. 2005;28(3):281-293. https://doi.org/10.1007/s10865-005-4664-z
Popiołek A, Brzoszczyk B, Jarzemski P, et al. Quality of life of prostate cancer patients undergoing prostatectomy and affective temperament. Cancer Manag Res. 2022;14:1743-1755. https://doi.org/10.2147/cmar.s358054
Wootten AC, Burney S, Foroudi F, Frydenberg M, Coleman G, Ng KT. Psychological adjustment of survivors of localised prostate cancer: investigating the role of dyadic adjustment, cognitive appraisal and coping style. Psycho Oncol. 2007;16(11):994-1002. https://doi.org/10.1002/pon.1159
Bisson JI, Chubb HL, Bennett S, Mason M, Jones D, Kynaston H. The prevalence and predictors of psychological distress in patients with early localized prostate cancer. BJU Int. 2002;90(1):56-61. https://doi.org/10.1046/j.1464-410x.2002.02806.x
Boschloo L, Nolen WA, Spijker AT, et al. The Mood Disorder Questionnaire (MDQ) for detecting (hypo)manic episodes: its validity and impact of recall bias. J Affect Disord. 2013;151(1):203-208. https://doi.org/10.1016/j.jad.2013.05.078